首页 内部办公网 中文版 ENGLISH
当前位置:首页 > 学科建设 > 学术交流
6月6日学术讲座预告
( 发布日期:2019/6/3 阅读:次)

报告题目Investment in Building up a World Class Biomanufacturing in China

在中国投资建设世界级生物制造产业

   : 叶峰  博士  国家千人计划专家

报告时间201966(星期四)下 2:00

报告地点:下沙校区食品学院257报告厅

 

报告人简介

叶峰博士,国家千人计划专家,是生物制药行业经验丰富的高管人士,现任创胜集团技术运营高级副总裁,负责所有产品(单抗和融合蛋白)的生产和质量管理叶博士曾就读于华东师范大学,于美国俄勒冈大学获得学士和硕士学位,后于美国北卡大学获得生物统计学博士学位。叶博士曾在美国先灵葆雅、英国葛兰素史克、美国安进等公司从事药品生产和质量管理工作,至今已有20多年生物制药生产和质量管理及工厂设计和运营的丰富经验,熟谙有关企业质量管理战略的制定及执行,以及临床药和商业药的cGMP生产方面的知识和经验

创胜集团是一家在生物医药研究、开发和生产方面具有全整合能力的处于临床阶段的生物制药公司。公司已成功搭建了全球的业务布局:在苏州设有药物发现、转化研究和临床研究中心,在杭州拥有工艺与产品开发中心和下一代的 GMP 抗体药物生产基地,并在上海、北京和美国波士顿分别设有临床开发和报批中心。创胜集团的开发管线涵盖肿瘤和经筛选的非肿瘤领域的十余个新药分子。公司的使命是为全世界患者提供高质量及可支付得起的生物药。

Frank Ye, Ph.D., is currently Senior Vice President of Technical Operations in Transcenta Holding.  In this role he serves as the Head of Manufacturing Facility located in Hangzhou, China with the overall responsibility for operating a world-class next generation biological manufacturing facility aimed at accelerating development of biotherapeutics and substantially reducing their manufacturing cost.

Previously Dr. Ye was Director of Operations for Amgen Asia responsible for manufacturing and quality operations in Greater China Region including imported drug products, local manufacturing and joint ventures. Prior to his tenure in Amgen Asia, Dr. Ye worked at Amgen Headquarter in Thousand Oaks, CA as Director of Quality with responsibility of providing quality oversight aimed at maximizing effectiveness and efficiency of Amgen Quality Management system and processes. Dr. Ye had also worked in GlaxoSmithKline and Schering-Plough as Principal Statistical Scientist supporting pharmaceutical development and manufacturing. Dr. Ye holds a B.S. in Computer Sciences and a M.S. in Statistics from the University of Oregon, and a Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill.

 

报告摘要

        生物制药生产将如何推动技术创新具备速度和成本效益支持的灵活性,是未来生物制药的关键在更小、更灵活的设施中投资先进技术,以实现未来发展How Biopharmaceutical manufacturing will fuel technology innovation; Flexibility is key for future biomanufacturing, with speed and cost-effectiveness supporting; Investment in advance technology to reach future state in smaller and more flexible facilities.

 

 

 

    欢迎师生积极参加!

分享到:0
上一条: 食品科学与营养学科前沿论坛(第一轮通知) 2019/6/6
下一条: 5月20日学术讲座预告 2019/5/17
Copyright©2014 浙江工商大学食品与生物工程学院 版权所有 技术支持:名冠电商
浙江省杭州市下沙高教园区学正街18号 联系电话:(86)571-28008900
E-mail:spxy@zjsu.edu.cn 浙ICP备05073962号 浙公网安备33011802000512号 网站管理
 
友情链接